Business Wire

New cutting-edge tools coming to the Grin Portal redefine efficiency and precision, empowering doctors in today’s evolving healthcare landscape

NEW YORK--(BUSINESS WIRE)-- Grin, the leading virtual care platform for digital oral healthcare solutions, is proud to introduce its new groundbreaking treatment tracking technology, The Grin 3D Tx Tracker™, and a suite of highly efficient tools to enhance the Grin Premium experience at the American Association of... (continue reading...)

Article co-authored by Dr. Gloria Littlemouse grounded in Watson theory of Caring Science identified barriers to self-care and potential of coaches to help nurses build resilience

PHOENIX--(BUSINESS WIRE)-- University of Phoenix College of Nursing is pleased to highlight the recent publication by alumna Gloria Littlemouse, Ph.D. in Nursing, MSN, RN, WCSI Scholar, whose dissertation study informed an article, “Lived Experiences of ICU Nurses During COVID-19,”... (continue reading...)

• One-day, high-impact event will focus on issues facing public companies applicable to investor relations, finance, and communications teams at all levels.
• Join Nasdaq with NIRI chapters of Los Angeles, Orange County, and San Diego on May 16th, 2024, in Irvine, CA.

IRVINE, Calif. & SAN DIEGO & LOS ANGELES--(BUSINESS WIRE)-- Insert the following at end of "ESG at Crossroads" panel discussion section of release issued April 29, 2024:

Megan Bloomer, PhD,... (continue reading...)

OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best has revised the outlook to negative from stable for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term ICRs of “a+” (Excellent) of Builders Mutual Insurance Company and Builders Premier Insurance Company, collectively referred to as Builders Mutual Insurance Group (Builders Mutual) (Raleigh, NC). The outlook of the FSR is stable.

The... (continue reading...)

LOS ANGELES--(BUSINESS WIRE)-- AIDS Healthcare Foundation (AHF) voiced support for the U.S. Federal Trade Commission (FTC) taking action this week to challenge several major pharmaceutical companies, including GSK, for anticompetitive use of so-called junk patents that prevent generic competition and keep drug prices artificially high.

“Big pharma is abusing the patent system by filing multiple derivative patents on existing drugs – which is not innovation –... (continue reading...)